OCM
LSB

Ovata Capital Management’s LakeShore Biopharma LSB Stock Holding History

Ovata Capital Management’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,000
Closed -$10.2K – 43
2024
Q2 		$10.2K Buy
+15,000
New +$123K 0.01% 38

Other funds holding LSB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ovata Capital Management's LSB Position: Q3 2024 in Review

Ovata Capital Management sold out of LakeShore Biopharma (LSB) in Q3 2024, closing a stake of 15,000 shares — an estimated $10.2K sold.

Ovata Capital Management first reported a position in LSB in Q2 2024 and held it in 1 quarter. The position peaked at $10.2K in Q2 2024. 7 funds tracked by Wall St. Rank hold LSB as of Q3 2024.

  • Ovata Capital Management reported no remaining LakeShore Biopharma position as of Q3 2024 after selling out during the quarter.
  • Ovata Capital Management sold 15,000 LakeShore Biopharma shares in Q3 2024, an estimated $10.2K.
  • Ovata Capital Management first reported a position in LakeShore Biopharma in Q2 2024 and held it in 1 quarter.
  • Ovata Capital Management's LakeShore Biopharma position peaked at $10.2K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q3 2024.

Based on Ovata Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.